Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Chemoprophylaxis Approaches After Phacoemulsification
NCT03634852Phase 4Completed
- Start
- Oct 2016
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial in endophthalmitis and ocular inflammation comparing Topical Moxifloxacin + Dexamethasone with Intracameral Moxifloxacin + Subconjunctival Triamcinolone (2 arms). Primary endpoint: Incidence of Bacterial Endophthalmitis at 3 months. Started Oct 2016; status: completed.
02
Drugs
Moxisurgetriamcinolone
03
Conditions
endophthalmitisocular inflammation
Beyond the preview
Go deeper on NCT03634852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03634852.